| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.0033 | 1 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |